The authors showed that RIPK3 loss induced tumorigenesis via upregulation of NF-κΒ, STAT3, AKT, and Wnt-β-catenin pathways activation, thus in turn leading to aberrant tumor cell proliferation, colon inflammation, immune cell infiltration and finally CRC. This evidence concerns the gene RIPK3 and neoplasm.